Update on the Management of Gastroenteropancreatic Neuroendocrine Tumors With Emphasis on the Role of Imaging

被引：31

作者：

Kim, Kyung Won ^{[1
,2
,3
]}

Krajewski, Katherine M. ^{[1
]}

Nishino, Mizuki ^{[1
]}

Jagannathan, Jyothi P. ^{[1
]}

Shinagare, Atul B. ^{[1
]}

Tirumani, Sree Harsha ^{[1
]}

Ramaiya, Nikhil H. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Radiol, Boston, MA 02115 USA

[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea

[3] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea

来源：

AMERICAN JOURNAL OF ROENTGENOLOGY | 2013年 / 201卷 / 04期

基金：

美国国家卫生研究院;

关键词：

gastroenteropancreatic neuroendocrine tumor; guidelines; molecular targeted therapy; CLINICAL-PRACTICE GUIDELINES; CARCINOID-TUMORS; SOMATOSTATIN; METASTASIS; NEOPLASMS; DIAGNOSIS; ERA;

D O I：

10.2214/AJR.12.10240

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

OBJECTIVE. The purposes of this article are to review the current management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) based on the 2012 National Comprehensive Cancer Network guidelines and to describe the role of imaging in a multidisciplinary approach. CONCLUSION. The management of GEP-NETs has become complex, requiring a multidisciplinary approach. The World Health Organization classification of GEP-NETs has been revised; the U.S. Food and Drug Administration has approved molecular targeted agents (sunitinib, everolimus) for the treatment of pancreatic NETs; and the National Comprehensive Cancer Network clinical practice guidelines have been updated.

引用

页码：811 / 824

页数：14

共 50 条

[21] Gastroenteropancreatic Neuroendocrine Tumors
Cives, Mauro
Strosberg, Jonathan R.
[J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) : 471 - 487
[22] Gastroenteropancreatic neuroendocrine tumors
Rayes, Nada
Denecke, Timm
[J]. ONKOLOGE, 2021, 27 (05): : 511 - 520
[23] Gastroenteropancreatic Neuroendocrine Tumors
Breitling, Lutz Philipp
Rinke, Anja
Gress, Thomas Mathias
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (21) : 1509 - 1519
[24] Somatostatin receptors imaging in gastroenteropancreatic neuroendocrine tumors.
Mura, A
Lebtahi, R
de Labriolle-Vaylet, C
Askienazy, S
[J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1998, 22 (10): : 809 - 818
[25] Gastroenteropancreatic Neuroendocrine Tumors
Kotagal, Meera
von Allmen, Daniel
[J]. SEMINARS IN PEDIATRIC SURGERY, 2020, 29 (03)
[26] Gastroenteropancreatic neuroendocrine tumors
Rayes, Nada
Denecke, Timm
[J]. GASTROENTEROLOGE, 2021, 16 (06): : 469 - 479
[27] Gastroenteropancreatic Neuroendocrine Tumors
Fernandes, Conrad J.
Leung, Galen
Eads, Jennifer R.
Katona, Bryson W.
[J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (03) : 625 - 647
[28] Gastroenteropancreatic neuroendocrine tumors
Rayes, Nada
Denecke, Timm
[J]. RADIOLOGE, 2021, 61 (12): : 1129 - 1138
[29] Proposal of a treatment algorithm for the management of gastroenteropancreatic neuroendocrine tumors
Bajetta, Emilio
[J]. TUMORI, 2010, 96 (05) : 852 - 855
[30] THE CLINICAL USE OF INTERFERONS IN THE MANAGEMENT OF NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS
OBERG, K
ERIKSSON, B
JANSON, ET
[J]. MOLECULAR AND CELL BIOLOGICAL ASPECTS OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE, 1994, 733 : 471 - 478

← 1 2 3 4 5 →